If you are trying to figure out whether Recursion Pharmaceuticals is attractively priced or a high risk speculation, a useful starting point is understanding what the current market price might be ...

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI ...

Last year's weakness is ultimately an improved entry opportunity for long-term-minded investors.

It's a potential game-changing technology. The company just needs to prove to the world that it works well enough.

At least nine engineers, including two co-founders, have announced their exits from xAI in the past week, fueling online ...

Redundancy does not stay located at headquarters either; it follows the family home and hides in the nursery. For the ...

AI co-founders Tony Wu and Jimmy Ba announced on X that they have quit the AI start-up, adding their name in the list of ...

Cathie Wood’s ARK Invest continued trimming its exposure to Coinbase on Friday, selling roughly $22 million worth of shares across three exchange-traded ...

Cathie Wood's ARK bought $9.67M in Roblox stock Feb 9 while selling PagerDuty for fifth day. Full breakdown of ARK Invest ...

Future AI-guided genomic analysis offers the potential to further optimize gene constructs, expression profiles, and performance traits, accelerating the development of next-generation materials.

AI agents are having consciousness debates on Moltbook without us. What this Reddit for AI reveals about human-AI collaboration's future.